The higher he climbs, the less he thinks about daily life, says Novo Nordisk’s Cem Ozenc. There’s no time when the mental and ...

Iván Romeo secured his first professional victory racing for Movistar with a solo win on stage 3 at the Volta a la Comunitat ...

Santiago Buitrago gave Bahrain Victorious their first win of 2025 on the Alto de Partegat hilltop finish at the Volta a ...

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep ...

In the pharmaceuticals sector, Novo Nordisk is due to report, coming off the back of some positive developments for its weight-loss drugs. Fellow pharma giant AstraZeneca is also set to release ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money, has been ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. In his recent appearance on CNBC's Squawk on the Street, Jim Cramer started the ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...

Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it could work better than the obesity blockbusters already on the market.